This 2022 meta-analysis assessed the long-term outcomes of non-functioning pituitary adenomas (NFPAs) managed conservatively without surgical intervention. Data from 19 studies involving 1,057 patients indicated that macroadenomas had a significantly higher risk of tumor growth (34%) and apoplexy (5%) than microadenomas (12% growth,
